Engineering the TGFβ receptor to enhance the therapeutic potential of natural killer cells as an immunotherapy for neuroblastoma von Burga, R.A, Williams, E, Yvon, E, Fernandes, R, Cruz, C.Y, Bollard, C

Volltext

Towards Prepared mums (TOP-mums) for a healthy start, a lifestyle intervention for women with overweight and a child wish: study protocol for a randomised controlled trial in the N... von Timmermans, Yvon E G, van de Kant, Kim D G, Reijnders, Dorien, Kleijkers, Lina M P, Dompeling, Edward, Kramer, Boris W, Zimmermann, Luc J I, Steegers-Theunissen, Régine P M, Spaanderman, Marc E A, Vreugdenhil, Anita C E

Volltext

Dasatinib Inhibits the Growth of Molecularly Heterogeneous Myeloid Leukemias von GUERROUAHEN, Bella S, FUTAMI, Muneyoshi, KORNBLAU, Steven M, WIEDER, Eric, CAYRE, Yvon E, COREY, Seth J, VAKLAVAS, Christos, KANERVA, Jukka, WHICHARD, Zakary L, NWAWKA, Kenechi, BLANCHARD, Elisabeth G, LEE, Francis Y, ROBINSON, Lisa J, ARCECI, Robert

Volltext

Medulloblastoma rendered susceptible to NK-cell attack by TGFß neutralization von Cruz, C, Powell, A, Yadavilli, S, Van Pelt, S, Saunders, D, Burga, R.A, Albihani, S, Williams, E, Hanley, P, Pei, Y, Yvon, E, Hwang, E, Bollard, C, Nazarian, J

Volltext

JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells von Moog-Lutz, Christel, Cavé-Riant, Florence, Guibal, Florence C., Breau, Marie A., Di Gioia, Yolande, Couraud, Pierre Olivier, Cayre, Yvon E., Bourdoulous, Sandrine, Lutz, Pierre G.

Volltext

Developing an nk cell-based immunotherapy against mesothelioma von Bonan, N., Yvon, E., Fernandes, R.

Volltext

Generation and administration of autologous T cells transduced with a 3rd generation GD2 chimeric antigen receptor for patients with relapsed or refractory neuroblastoma von Louis, C.U, Savoldo, B, Heczey, A, Yvon, E, Gee, A, Rooney, C, Heslop, H, Dotti, G, Brenner, M.K

Volltext

A bispecific chimeric antigen receptor targeting antigen escape variants in glioblastoma von Hegde, M, Corder, A, Grada, Z, Byrd, T.T, Chow, K.K, Brawley, V.S, Krebs, S.S, Heslop, H, Gottschalk, S, Yvon, E, Ahmed, N

Volltext

Gene Editing/Gene Therapies: HUMAN ALLOGENEIC NK CELLS MODIFIED TO EXPRESS A TGF-β DOMINANT NEGATIVE RECEPTOR AND IL-15 DISPLAY A STRONG ANTI-TUMOR ACTIVITY IN AN NSG MOUSE MODEL O... von Bonan, N., Chen, J., Ghofrani, J.T., Medina, J.A., Bollard, C., Yvon, E., Fernandes, R.

Volltext

Immunotherapy: COMPARABLE TGF-β MEDIATED IMMUNE SUPPRESSION IN EX VIVO EXPANDED NK CELLS FROM CORD BLOOD AND PERIPHERAL BLOOD: IMPLICATIONS FOR ADOPTIVE IMMUNOTHERAPY von Chaudhry, K., Dowlati, E., Long, M., Geiger, A., Lang, H., Sanchez, C., Yvon, E., Bollard, C., Cruz, C.

Volltext

Immunotherapy: B7H3-CAR NK CELLS AND DNR CO-TRANSDUCED NK SHOWS MAINTAIN THEIR POTENCY AGAINST TGF-B MEDIATED IMMUNE SUPPRESSION von Chaudhry, K., Geiger, A., Dowlati, E., Lang, H., Yvon, E., Holdoff, M., Jones, R., Savoldo, B., Cruz, C., Bollard, C.

Volltext

PRAM-1 Potentiates Arsenic Trioxide-induced JNK Activation von Denis, Frédéric M., Benecke, Arndt, Di Gioia, Yolande, Touw, Ivo P., Cayre, Yvon E., Lutz, Pierre G.

Volltext

In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33^+ Acute Myeloid Leukemia von Marin, Virna, Dutour, A., Pizzitola, I., Valsesia-Wittmann, S., Lee, D., Yvon, E., Finney, H., Lawson, A., Brenner, M., Biondi, A., Biagi, Ettore, Rousseau, R.

Volltext

Why implantation of bio‐loggers may improve our understanding of how animals cope within their natural environment von FORIN‐WIART, Marie‐Amélie, ENSTIPP, Manfred R., LE MAHO, Yvon, HANDRICH, Yves

Volltext

Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease von Cavazzana-Calvo, Marina, Hacein-Bey, Salima, Geneviève de Saint Basile, Gross, Fabian, Yvon, Eric, Nusbaum, Patrick, Selz, Françoise, Hue, Christophe, Certain, Stéphanie, Casanova, Jean-Laurent, Bousso, Philippe, Le Deist, Françoise, Fischer, Alain

Volltext

2 - Engineering the TGFβ receptor to enhance the therapeutic potential of natural killer cells as an immunotherapy for neuroblastoma von Burga, R.A., Williams, E., Yvon, E., Fernandes, R., Cruz, C.Y., Bollard, C.

Volltext

Catching-up but telomere loss: half-opening the black box of growth and ageing trade-off in wild king penguin chicks von GEIGER, SYLVIE, LE VAILLANT, MARYLINE, LEBARD, THOMAS, REICHERT, SOPHIE, STIER, ANTOINE, LE MAHO, YVON, CRISCUOLO, FRANCOIS

Volltext

Population dynamics in a long-lived seabird: I. Impact of breeding activity on survival and breeding probability in unbanded king penguins von BOHEC, CÉLINE LE, GAUTHIER-CLERC, MICHEL, GRÉMILLET, DAVID, PRADEL, ROGER, BÉCHET, ARNAUD, GENDNER, JEAN-PAUL, MAHO, YVON LE

Volltext

The effect of migration strategy and food availability on White Stork Ciconia ciconia breeding success von MASSEMIN-CHALLET, SYLVIE, GENDNER, JEAN-PAUL, SAMTMANN, SÉBASTIEN, PICHEGRU, LORIEN, WULGUÉ, ANITA, LE MAHO, YVON

Volltext

Prevention of EBV‐induced B‐lymphoproliferative disorder by ex vivo marrow B‐cell depletion in HLA‐phenoidentical or non‐identical T‐depleted bone marrow transplantation... von CAVAZZANA-CALVO, M, BENSOUSSAN, D, LE DEIST, F, FISCHER, A, JABADO, N, HADDAD, E, YVON, E, MOSKWA, M, TACHET DE COMBES, A, BUISSON, M, MORAND, P, VIRION, J. M

Volltext